The prospects for developing a vaccine against Staphylococcus aureus
- PMID: 8728611
- DOI: 10.1016/0966-842x(96)10021-4
The prospects for developing a vaccine against Staphylococcus aureus
Abstract
Staphylococcus aureus is an important bacterial pathogen with multiple virulence factors. The prevalence of antibiotic resistance among clinical isolates means that new vaccine strategies to prevent staphylococcal infections are needed. An ideal vaccine would induce antibodies to prevent bacterial adherence, promote opsonophagocytic killing by leukocytes and neutralize toxic secreted proteins.
Similar articles
-
Staphylococcus aureus: the current state of disease, pathophysiology and strategies for prevention.Expert Rev Vaccines. 2016 Nov;15(11):1373-1392. doi: 10.1080/14760584.2016.1179583. Epub 2016 May 9. Expert Rev Vaccines. 2016. PMID: 27118628 Review.
-
Prospects for a MRSA vaccine.Future Microbiol. 2007 Feb;2(1):1-3. doi: 10.2217/17460913.2.1.1. Future Microbiol. 2007. PMID: 17661669 No abstract available.
-
Is there a future for a Staphylococcus aureus vaccine?Vaccine. 2012 Apr 19;30(19):2921-7. doi: 10.1016/j.vaccine.2011.11.006. Epub 2011 Nov 21. Vaccine. 2012. PMID: 22115633 Review.
-
A vaccine to prevent infections with Staphylococcus aureus.Med Sci Monit. 2002 Sep;8(9):LE35-6. Med Sci Monit. 2002. PMID: 12365409 No abstract available.
-
Prospects for active and passive immunization against Staphylococcus aureus.Pediatr Infect Dis J. 2006 Feb;25(2):167-8. doi: 10.1097/01.inf.0000199887.18267.9a. Pediatr Infect Dis J. 2006. PMID: 16462297 Review. No abstract available.
Cited by
-
Synthetic peptide immunogens elicit polyclonal and monoclonal antibodies specific for linear epitopes in the D motifs of Staphylococcus aureus fibronectin-binding protein, which are composed of amino acids that are essential for fibronectin binding.Infect Immun. 2000 Mar;68(3):1156-63. doi: 10.1128/IAI.68.3.1156-1163.2000. Infect Immun. 2000. PMID: 10678920 Free PMC article.
-
Comparison of Staphylococcus aureus surface protein extraction methods and immunogenicity.Heliyon. 2019 Oct 23;5(10):e02528. doi: 10.1016/j.heliyon.2019.e02528. eCollection 2019 Oct. Heliyon. 2019. PMID: 31687478 Free PMC article.
-
Selection and characterization of murine monoclonal antibodies to Staphylococcus aureus iron-regulated surface determinant B with functional activity in vitro and in vivo.Clin Vaccine Immunol. 2009 Aug;16(8):1095-104. doi: 10.1128/CVI.00085-09. Epub 2009 Jun 24. Clin Vaccine Immunol. 2009. PMID: 19553551 Free PMC article.
-
A mutant of staphylococcal enterotoxin C devoid of bacterial superantigenic activity elicits a Th2 immune response for protection against Staphylococcus aureus infection.Infect Immun. 2005 Jan;73(1):174-80. doi: 10.1128/IAI.73.1.174-180.2005. Infect Immun. 2005. PMID: 15618152 Free PMC article.
-
An evaluation of the emerging vaccines and immunotherapy against staphylococcal pneumonia in children.BMC Public Health. 2011 Apr 13;11 Suppl 3(Suppl 3):S27. doi: 10.1186/1471-2458-11-S3-S27. BMC Public Health. 2011. PMID: 21501445 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical